Single-agent thalidomide for treatment of first relapse following high-dose chemotherapy in patients with multiple myeloma [11]

R. Fenk, B. Hoyer, U. Steidl, M. Kondakci, T. Graef, R. Heuk, L. Ruf, C. Strupp, F. Neumann, U. P. Rohr, B. Hildebrandt, R. Haas, G. Kobbe

Research output: Contribution to journal › Letter › peer-review